This article provides nomenclature recommendations developed by an international workgroup to increase transparency and standardization of pharmacogenetic (PGx) result reporting. Presently, sequence variants identified by PGx tests are described using different nomenclature systems.
In addition, PGx analysis may detect different sets of variants for each gene, which can affect interpretation of results. This practice has caused confusion and may thereby impede the adoption of clinical PGx testing. Standardization is critical to move PGx forward.

dx.doi.org/10.1002/cpt.280, hdl.handle.net/1765/85206
Clinical Pharmacology and Therapeutics
Erasmus MC: University Medical Center Rotterdam

Kalman, L.V, Agúndez, J.A.G, Appell, M.L, Black, J.L, Bell, G.C, Boukouvala, S, … Zanger, U. (2016). Pharmacogenetic Allele Nomenclature. Clinical Pharmacology and Therapeutics, 99(2), 172–185. doi:10.1002/cpt.280